Human GRO alpha (CXCL1) ELISA KIT (96 T)
CNY 3200.00
货期*
3周
规格
Specifications
| Product Data | |
| Description | Human CXCL1 Immunoassay |
| Size | 96 T |
| Format | 96-well strip plate |
| Assay Type | Solid Phase Sandwich ELISA |
| Assay Length | 4 hours |
| Signal | Colorimetric |
| Curve Range | 15.62-1000pg/ml |
| Sample Type | Serum, plasma, Cell culture supernatant |
| Sample Volume | 100 uL |
| Specificity | This assay recognizes both natural and recombinant human CXCL1. |
| Sensitivity | 8pg/mL |
| Reactivity | Human |
| Interference | No significant interference observed with available related molecules. |
| Components |
|
| Background | GROα, or CXCL1, was initially discovered as a growth-regulated gene that is overexpressed constitutively in tumorigenic cells and transcribed in normal cells only during growth stimulation. The GROα cDNA encodes a 107 aa precursor protein from which the N-terminal 34 aa residues are cleaved to generate the 73 aa residue mature GROα. There are no potential N-linked glycosylation sites in the aa sequence nor does the mature protein appear to undergo any post-translational modifications. GROα exhibits growth stimulatory activity for the human Hs294T melanoma cell line from which it was initially isolated. As a chemokine α member, GROα, like IL-8, is a potent chemoattractant for human neutrophils and stimulates neutrophil degranulation and enzyme release from cytochalasin B-treated human neutrophils. It has been demonstrated that GROα can cause a decrease in the expression of interstitial collagens by rheumatoid synovial fibroblasts. In in vivo experiments, GROα has been shown to induce an acute inflammatory reaction when injected into the foot-pads of endotoxin resistant mice. |
| Gene Symbol | CXCL1 |
| Locus ID | 2919 |
Documents
| Product Manuals |
Customer
Reviews
Loading...
